Stoke Therapeutics Inc.
STOK | NASDAQ
$28.05
-$0.38 (-1.34%)
At close: Sep 21, 2026, 4:00 PM ET
$27.66
-$0.39 (-1.39%)
After-hours:
Sep 21, 2026, 7:54 PM ET
Market Data
Market Cap $1.81B
Enterprise Value $1.52B
Beta 1.23
Average Volume 778.81K
Shares Outstanding (Diluted) 66.02M
Shares Change YoY 13.13%
Institutional Ownership N/A
Exchange NASDAQ
ISIN US86150R1077
Price Performance
Price Change 1M -13.1%
Price Change 3M -9.8%
Price Change 6M -17.0%
Price Change YTD -9.2%
Price Change 1Y 22.8%
Price Change 3Y 571.0%
Price Change 5Y 7.9%
1M CAGR (ann.) -14.3%
1Y CAGR (ann.) 19.4%
5Y CAGR (ann.) 2.0%
All-Time CAGR 1.3%
Valuation
PE Ratio -8.35
Forward PE N/A
PEG Ratio -0.06
Forward PEG 3.79
PS Ratio 65.61
Forward PS 40.40
PB Ratio 5.24
P/FCF Ratio -10.02
P/Adj. FCF Ratio -8.62
P/OCF Ratio -10.39
EV/Sales 55.09
EV/EBIT -7.25
EV/EBITDA -7.40
EV/FCF -8.41
Earnings Yield -12.0%
FCF Yield -10.0%
Adj. FCF Yield -11.6%
Financial Health
Net Cash $290.97M
Total Debt $2.68M
Cash & Short-Term Investments $292.82M
Total Assets $393.97M
Current Ratio 7.69
Quick Ratio 7.69
Debt / Equity Ratio 0.01
Debt / EBITDA -0.01
Debt / FCF -0.01
OCF / Debt -66.36
Interest Coverage -4,856.02
Altman Z-Score 19.43
Piotroski F-Score 2
Margins & Profitability
Gross Profit Margin 84.7%
Operating Profit Margin -809.7%
EBITDA Margin -744.4%
Net Profit Margin -753.6%
FCF Margin -654.9%
Adj. FCF Margin -761.5%
SBC / Revenue 106.6%
SBC Impact (per share) -16.3%
Returns
Return on Assets -52.8%
Return on Equity -59.4%
Return on Invested Capital -62.7%
Return on Capital Employed -63.5%
Return on Tangible Assets -52.8%
Historical Growth (CAGR)
Revenue CAGR 3Y 46.1%
Revenue CAGR 5Y 45.4%
Revenue CAGR 10Y N/A
EPS CAGR 3Y -37.7%
EPS CAGR 5Y 7.6%
EPS CAGR 10Y N/A
FCF CAGR 3Y -75.0%
FCF CAGR 5Y -27.0%
FCF CAGR 10Y N/A
Analyst Forecasts
Analyst Rating Buy
Analyst Count 16
EPS Growth Next 3Y 32.1%
Revenue Growth Next 3Y 135.0%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) -$0.88
EPS Growth Est (next Q) 35.4%
Revenue Est (next Q) $8.21M
Revenue Growth Est (next Q) -22.8%
Fair Value Estimates
Graham Number N/A
Graham Upside N/A
Lynch Fair Value N/A
Lynch Upside N/A
Price Target $51
Price Target Upside 81.8%
Cash Flow
Operating Cash Flow $-177.99M
Free Cash Flow $-180.68M
Adj. Free Cash Flow $-210.08M
FCF Per Share -$2.74
OCF Per Share -$2.70
OCF/S Ratio -645.2%
Income Statement
Revenue $27.59M
Gross Profit $23.36M
Operating Income $-223.38M
EBITDA $-205.36M
Net Income $-207.9M
EPS (Diluted) -$3.36
Revenue / Employee $162.28K
Profit / Employee $-1.22M
Employees 170
Add to Watchlist
Select watchlists to add or remove STOK